Masakazu Tokura, President PLAY LIST from the beginning Current Priority Management Issues and Business Strategy Contents Performance Trends FY2018 1H vs. FY2017 1H FY2018 1H Core Operating Income by Sector vs. FY2017 1H Dividend Policy Progress on Corporate Business Plan (Overall) Corporate Business Plan: Basic Policy FY2018 Forecast vs. FY2018 Target Corporate Business Plan: Medium- to Long-term vs. FY2018 Performance Targets Capital Expenditure and Investment Forecast for FY2016-FY2018 (decision-making basis) Capital Expenditure and Investment Plan for FY2016-FY2018 (decision-making basis) Research and Development Expenses Plan for FY2016-FY2018 Major Investments and Commercialization Schedule (Overall) Major Investments and Commercialization Schedule (Overall) Change in Business Portfolio Changes in Our Business Portfolio Management of Cash Flow Business Strategy and Topics (by Sector) Petrochemicals & Plastics: Challenges and Business Strategy and Progress Status Petrochemicals & Plastics: Expanding the Technology Licensing Business Petrochemicals & Plastics: Rabigh Phase II Project Energy & Functional Materials: Challenges and Business Strategy/Progress Energy & Functional Materials: Expand the Lithium-ion Secondary Battery Separators Business Energy & Functional Materials: Expansion of Liquid Crystal Polymer (LCP) business IT-related Chemicals: Challenges and Business Strategy/Progress on Strategic Initiatives IT-related Chemicals: Business Development for Medium-size Displays Applications IT-related Chemicals: Commercialization of Polymer OLED Materials IT-related Chemicals: Compound Semiconductor Business Development for Automotive Applications Major Products in the Mobility Sector Health & Crop Sciences: Challenges and Business Strategy/Progress on Strategic Initiatives Health & Crop Sciences: Strengthening Crop Protection Business India Health & Crop Sciences: Progress in Pipeline Development Health & Crop Sciences: Expansion of Our Biorational Business Pharmaceuticals: Progress on Strategic Initiatives Status of LATUDA ANDA litigations (U.S. Patent No.9,815,827 / 9,907,794) Pharmaceuticals: Initiatives in Regenerative Medicine & Cell Therapy Business Pharmaceuticals: Initiatives in Nucleic Acid Medicine Pharmaceuticals: Nihon Medi-Physics Expansion of Healthcare Businesses Direction of Future Business Strategy Management Strategy and Performance Trends from the early 21st century Current Management Strategy and Performance Trends: Management by Phase Initiatives for Global Environment Issues Initiatives for Global Environment Issues Initiatives for Global Environment Issues Initiatives for Global Environmental Issues The Issue of Plastic Waste The Issue of Plastic Waste Drastic Improvement of Productivity through Digital Innovation Digital Innovation in Production and Research Digital Innovation in Production and Research Digital Innovation in Production and Research Initiatives to Accelerate Innovation Collaboration with Start-up Companies Promote Open Innovation Promote Open Innovation Initiatives for Sustainability Initiatives for Sustainability (External Evaluation) Held the Second Sustainability Promotion Committee What Sumitomo Chemical Strives To Be Cautionary Statement Back Next